Home › Bipolar Disorder › Georgia
Bipolar Disorder clinical trials in Georgia
9 studies for Bipolar Disorder are looking for participants at sites in Georgia.
Cities in Georgia
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- CenExeli Research LLC, Atlanta
- CenExeli Research LLC 1, Savannah
RecruitingPhase 3
Ages 10 to 17 · All sexes · Updated Sep 25, 2026 · NCT06372964Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- CenExeli Research LLC, Atlanta
- Atlanta Center for Medical Research, Atlanta
- CenExeli Research LLC 1, Savannah
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 25, 2026 · NCT06229210A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
- Atlanta Center for Medical Research, Atlanta
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 22, 2026 · NCT07286175A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Augusta
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07105111A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
- Synexus Clinical Research, Inc., Atlanta
- Atlanta Center for Medical Research, Atlanta
- CenExel iResearch, Decatur
- and 1 more
RecruitingPhase 3
Ages 18 to 74 · All sexes · Updated Sep 2, 2026 · NCT07172516A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
- Georgia Psychiatric Consultants and Advanced Discovery Research /ID# 279438, Atlanta
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Aug 14, 2026 · NCT06696755Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
- Bioxcel Clinical Research Site, Decatur
RecruitingPhase 1
Ages 10 to 17 · All sexes · Updated Aug 11, 2026 · NCT05025605A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
- CenExel iResearch, LLC, Savannah
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jun 23, 2026 · NCT07140913Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Georgia, Athens
RecruitingObservational study
Ages 18 to 40 · All sexes · Updated Mar 10, 2026 · NCT06740383From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.